The Journal of Materials Chemistry B has issued a laundry list of corrections for a 2014 chemotherapy paper, which address re-use of “some text”, incorrectly stated doses, and miscalculations of the drug concentration, among other issues. The paper described a new way to deliver gemcitabine via nanoparticles, focusing the drug on the tumors. It turns out the … Continue reading Drug paper gets a fix, notching several corrections
This week at Retraction Watch featured 43 papers retracted at once for fake peer reviews. Here’s what was happening elsewhere:
This week at Retraction Watch featured retractions by a high-profile cancer researcher, and a loss in court for PubPeer. Here’s what was happening elsewhere:
A group of researchers at two universities in South Korea have retracted two cell biology papers featuring retinoic acid. The most recent retraction appears in the Journal of Biological Chemistry. Although, in typical JBC fashion, the reason for it is anyone’s guess. Here’s the unhelpful notice for “ASXL1 represses retinoic acid receptor-mediated transcription through associating … Continue reading Cell biologists in South Korea retract two papers
This week at Retraction Watch featured the retraction of yet another spoof article, and the temporary shutdown of a journal. Here’s what was happening elsewhere:
The week at Retraction Watch featured a number of legal cases by scientists trying to suppress criticism about their work. Here’s what was happening elsewhere:
It hasn’t been a good week for scientists going to court to silence criticism of their work. Yesterday, PubPeer won a near-complete victory in a case seeking the identities of their commenters. And also yesterday, a Massachusetts judge struck down — for the second time — a request by Mario Saad to remove expressions of … Continue reading Researcher loses second bid to quash Diabetes expressions of concern
PLoS ONE has just issued a 12-figure correction on a paper by Mario A. Saad, who sued the American Diabetes Association unsuccessfully in an attempt to prevent it from retracting four papers in its flagship journal Diabetes. The corrections include taking out Western blots copied from another Saad paper, as well as several figures where the bands … Continue reading PLoS ONE mega-correction, but no retraction, for researcher who sued diabetes journal
A team of researchers whose work is under investigation by University College London has retracted a second paper. Three of the 11 authors of the 2005 Journal of Cell Science paper being retracted — David Latchman, Richard Knight, and Anastasis Stephanou — were authors of a Journal of Biological Chemistry paper retracted in January. Stephanou … Continue reading Prominent geneticist David Latchman’s group notches second retraction
Several journals have retracted or corrected papers from a group at State University of Maringá in Brazil over what one chemistry journal calls “fraudulent use” of figures previously published by the authors. Química Nova, which is retracting a 2013 paper, issued a notice that taps an additional eight articles with Angelica Lazarin as the corresponding author … Continue reading Several chem journals neutralize papers from Brazil group over figure fraud